N. Sibert

Which EORTC QLQ-C30 and -CR29 scores are relevant for clinicians for therapy planning and decisions?

T. Seufferlein, S. Post, C. Kowalski, 2021, coloproctology.

Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer

T. Knoll, B. Beyer, M. Burchardt, 2022, World Journal of Urology.

Quality assurance and improvement in oncology using guideline-derived quality indicators – results of gynaecological cancer centres certified by the German cancer society (DKG)

C. Dannecker, U. Wagner, J. Sehouli, 2022, Journal of Cancer Research and Clinical Oncology.

Predictors for the utilization of social service counseling by prostate cancer patients

T. Knoll, B. Beyer, M. Brock, 2021, Supportive Care in Cancer.

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

E. Inwald, J. Blohmer, W. Friedmann, 2022, Journal of Cancer Research and Clinical Oncology.

Implementing quality metrics in European Cancer Centers (ECCs)

S. Wesselmann, N. Sibert, E. Griesshammer, 2020, World Journal of Urology.

Cord blood telomere shortening associates with increased gestational age and birth weight in preterm neonates.

T. Brümmendorf, T. Orlikowsky, W. Wagner, 2021, Experimental and therapeutic medicine.